Vermischtes zu Allergien und Unverträglichkeiten

 Projekte

Veröffentlichungen

  • Bischoff SC. Mast cells in gastrointestinal disorders. Eur J Pharmacol 2016;778:139–45. doi:10.1016/j.ejphar.2016.02.018.
  • Rittmeyer D, Lorentz A. Allergies and cancers. In: Cancer Immunology: A Translational Medicine Context 2015:407–18. doi:10.1007/978-3-662-44006-3_21.
  • Hagenlocher Y, Feilhauer K, Schäffer M, Bischoff, S.C.Lorentz, A. Citrus peel polymethoxyflavones nobiletin and tangeretin suppress LPS- and IgE-mediated activation of human intestinal mast cells. Eur J Nutr 2016. doi:10.1007/s00394-016-1207-z.
  • Hagenlocher Y, Hösel A, Bischoff, S.C.Lorentz, A. Cinnamon extract reduces symptoms, inflammatory mediators and mast cell markers in murine IL-10−/− colitis. The Journal of Nutritional Biochemistry 2016;30:85–92. doi:10.1016/j.jnutbio.2015.11.015.
  • Baumann A, Feilhauer K, Bischoff, S.C., Froy O,Lorentz, A. IgE-dependent activation of human mast cells and fMLP-mediated activation of human eosinophils is controlled by the circadian clock. Mol Immunol 2015;64:76–81. doi:10.1016/j.molimm.2014.10.026.
  • Hagenlocher Y, Kießling K, Schäffer M, Bischoff, S.C.Lorentz, A.. Cinnamaldehyde is the main mediator of cinnamon extract in mast cell inhibition. Eur J Nutr 2015;54:1297–309. doi:10.1007/s00394-014-0810-0.
  • Hagenlocher YLorentz, A.. Immunomodulation of mast cells by nutrients. Mol Immunol 2015;63:25–31. doi:10.1016/j.molimm.2013.12.005.
  • Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff, S.C., Classen M, et al. Guideline for the management of IgE-mediated food allergies [Leitlinie zum Management IgE-vermittelter Nahrungsmittelallergien]. Allergo Journal 2015;24:38–77. doi:10.1007/s40629-015-0070-4.
  • Bischoff SC. Nahrungsmittelunverträglichkeiten. Deutsche Medizinische Wochenschrift 2014;139:1596–8. doi:10.1055/s-0034-1370198.
  • Fux M, Pecaric-Petkovic T, Odermatt A, Hausmann OV, Lorentz A, Bischoff SC, et al. IL-33 is a mediator rather than a trigger of the acute allergic response in humans. Allergy: European Journal of Allergy and Clinical Immunology. 2014;69:216–22. doi:10.1111/all.12309.
  • Baumann S, Lorentz A. Obesity - a promoter of allergy? Int Arch Allergy Immunol 2013;162:205–13. doi:10.1159/000353972.
  • Bischoff SC. Nahrungsmittelunverträglichkeiten. Akt Dermatol 2013;39:347–62. doi:10.1055/s-0033-1344355.
  • Bischoff SC. Nahrungsmittelunvertraglichkeiten - Update. Laryngorhinootologie 2012;91:720-35; quiz 736-8. doi:10.1055/s-0032-1327567.
  • Bischoff SC, Feuser K. Food Allergy and Intolerance. In: Textbook of Clinical Gastroenterology and Hepatology: Second Edition 2012. doi:10.1002/9781118321386.ch38.
  • Montier Y, Lorentz A, Kramer S, Sellge G, Schock M, Bauer M, et al. Central role of IL-6 and MMP-1 for cross talk between human intestinal mast cells and human intestinal fibroblasts. Immunobiology. 2012;217:912–9. doi:10.1016/j.imbio.2012.01.003.
  • Rittmeyer D, Lorentz A. Relationship between allergy and cancer: An overview. Int Arch Allergy Immunol 2012;159:216–25. doi:10.1159/000338994.
  • Latif S, Pfannstiel J, Makkar HPS, Becker K. Amino acid composition, antinutrients and allergens in the peanut protein fraction obtained by an aqueous enzymatic process. Food Chemistry. 2013;136:213–7. doi:10.1016/j.foodchem.2012.07.120.
  • Pickert CN, Lorentz, A., Manns MP, Bischoff, S.C. Colonoscopic allergen provocation test with rBet v 1 in patients with pollen-associated food allergy. Allergy: European Journal of Allergy and Clinical Immunology 2012;67:1308–15. doi:10.1111/all.12006.
  • Sherman H, Frumin I, Gutman R, Chapnik N, Lorentz, A., Meylan J, et al. Long-term restricted feeding alters circadian expression and reduces the level of inflammatory and disease markers. Journal of Cellular and Molecular Medicine 2011;15:2745–59. doi:10.1111/j.1582-4934.2010.01160.x.
  • Bischoff, S.C., Zeitz M. Scientific evidence for the medical use of probiotics. Annals of Nutrition and Metabolism 2010;57:1–5. doi:10.1159/000309008.
  • Frank SPC, Thon K, Bischoff SC, Lorentz A. SNAP-23 and syntaxin-3 are required for chemokine release by mature human mast cells. Mol Immunol. 2011;49:353–8. doi:10.1016/j.molimm.2011.09.011.
  • Lorentz A. Corecognition of pathogens: An important trigger for mast cell response? Int Arch Allergy Immunol 2011;154:183–4. doi:10.1159/000321104.
  • Bischoff SC. Food allergy and eosinophilic gastroenteritis and colitis. Curr Opin Allergy Clin Immunol 2010;10:238–45. doi:10.1097/ACI.0b013e32833982c3.
  • Bischoff SC, Feuser K. Nahrungsmittelallergie: An Kreuzreaktionen denken! MMW-Fortschritte der Medizin 2010;152:44.
  • Momma M, Steder-Neukamm U, Wedemeyer J, Manns MP, Köchling K, Bischoff SC. Allergische Erkrankungen und Reaktionen auf Nahrungsmittel bei Patienten mit chronisch-entzündlichen Darmerkrankungen. Aktuelle Ernahrungsmedizin 2010;35:301–9. doi:10.1055/s-0030-1265930.
  • Bischoff SC, Ulmer FA. Eosinophils and allergic diseases of the gastrointestinal tract. Best Practice and Research: Clinical Gastroenterology 2008;22:455–79. doi:10.1016/j.bpg.2007.11.010.
  • Sellge G, Bischoff SC. The Immunological Basis of IgE-Mediated Reactions. In: Metcalfe DD, Sampson HA, Simon RA, editors. Food allergy: Adverse reactions to foods and food additives. 4th ed. Malden, MA: Blackwell Pub; 2008. p. 15–28.
  • Bischoff SC. Food allergies. Current Treatment Options in Gastroenterology 2007;10:34–43. doi:10.1007/s11938-007-0055-6.
  • Bischoff SC. Food allergies. Current Gastroenterology Reports 2006;8:374–82. doi:10.1007/s11894-006-0022-8